HORUS PHARMA has a total of 42 patent applications. It increased the IP activity by 400.0%. Its first patent ever was published in 2010. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets pharmaceuticals, medical technology and machines are YS LAB, DOLISOS LAB and PK HOLDLINE B V.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 8 | |
#2 | WIPO (World Intellectual Property Organization) | 7 | |
#3 | United States | 6 | |
#4 | France | 5 | |
#5 | Canada | 4 | |
#6 | Hungary | 3 | |
#7 | Brazil | 2 | |
#8 | Republic of Korea | 2 | |
#9 | Taiwan | 2 | |
#10 | Japan | 1 | |
#11 | Mexico | 1 | |
#12 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Machines | |
#4 | Packaging and shipping | |
#5 | Organic fine chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Claret Martine | 24 |
#2 | Claret Claude | 14 |
#3 | Pozzi Jacques | 14 |
#4 | Gard Carole | 8 |
#5 | Roy Pierre | 5 |
#6 | Fessi Hatem | 5 |
#7 | Dubald Marion | 5 |
#8 | Bourgeois Sandrine | 5 |
#9 | Rouland Jean-François | 4 |
#10 | Lamprecht-Weissenborn Nicola | 3 |
Publication | Filing date | Title |
---|---|---|
FR3064482A1 | TOPICAL COMPOSITION OF DOXYCYCLINE | |
WO2015150459A1 | Hyperosmolar composition of hyaluronic acid | |
FR2986703A1 | DEVICE FOR PACKAGING AND DISPENSING A PRODUCT FOR OPHTHALMIC USE | |
FR2963240A1 | COMPOSITION FOR TOPICAL USE WITHOUT PRESERVATIVE COMPRISING HYALURONIC ACID | |
FR2962044A1 | LACRYMIMETIC EMULSION |